EGFR and cancer: Pathways associated with cancer and tumor metastasis were significantly enriched in the high-risk subgroup, including the PI3K pathway, EGFR pathway, hypoxia pathway, VEGF pathway, and WNT pathway, whereas immune-related pathways were more pronounced in the low-risk subgroup, including the IL2-STAT pathway.